1. Market Research
  2. > TrovaGene, Inc. (TROV) - Medical Equipment - Deals and Alliances Profile

Summary

TrovaGene, Inc. (TrovaGene), is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary diagnostic technologies for screening and monitoring of various diseases. The company’s proprietary urine-based molecular diagnostic tests are used in detection of transrenal DNA (TrDNA) and RNA (TrRNA). The technology is used in tumor detection and monitoring, prenatal genetic testing, infectious diseases, tissue transplantation, forensic identification, and for patient selection in clinical trials. It out-licenses its transrenal technologies to extend oncogene mutation detection using urine as a sample. The company has worldwide rights to worldwide rights to nucleophosmin-1 (NPM1), an informative biomarker for acute myelogenous leukemia (AML) and mutations in the SF3B1 gene. TrovaGene is headquartered in San Diego, California, the US.

TrovaGene, Inc. (TROV) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

TrovaGene, Inc. (TROV) - Medical Equipment - Deals and Alliances Profile
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
TrovaGene, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
TrovaGene, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
TrovaGene, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
TrovaGene, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 9
TrovaGene, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
TrovaGene, Inc., Medical Equipment, Deal Details 11
Asset Purchase 11
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 11
Partnerships 13
Trovagene Enters Into Licensing Agreement with GenSignia IP 13
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 14
TrovaGene Enters Into Licensing Agreement With Brunangelo Falini 15
TrovaGene Enters Into An Agreement With Skyline Diagnostics 16
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 17
TrovaGene Enters Into RandD Agreement With PerkinElmer Health Sciences 18
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 20
Equity Offering 21
Trovagene Raises USD40.3 Million in Public Offering of Shares 21
Trovagene Completes Public Offering of Shares for USD23 Million 23
Trovagene Completes Private Placement Of Shares For US$15 Million 25
Trovagene Completes Private Placement Of Units For US$4 Million 27
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 28
TrovaGene, Inc. - Key Competitors 30
Key Employees 31
Locations And Subsidiaries 32
Head Office 32
Other Locations and Subsidiaries 32
Recent Developments 33
Strategy And Business Planning 33
Feb 22, 2016: Trovagene Enters into Preferred Provider Agreement with Fortified Provider Network 33
Jan 21, 2015: Trovagene Expands Collaboration with Genomac to Demonstrate Clinical Utility in Lung and Colorectal Cancer Treatment Monitoring 34
Jan 12, 2015: Trovagene Collaborates with UC San Diego Moores Cancer Center to Demonstrate Clinical Utility of Detecting and Monitoring EGFR Mutations in Lung Cancer Patients 35
Financial Announcements 36
Mar 10, 2016: Trovagene Announces Fourth Quarter and Year End 2015 Financial Results 36
Nov 09, 2015: Trovagene Announces Third Quarter 2015 Financial Results 38
Aug 10, 2015: Trovagene Announces Second Quarter 2015 Financial Results 40
May 05, 2015: Trovagene Announces First Quarter 2015 Financial Results 41
Mar 12, 2015: Trovagene Reports Fourth Quarter and Full Year 2014 Financial Results 42
Corporate Communications 44
Mar 28, 2016: Trovagene Terminates the Employment of CEO Antonius Schuh and CFO Stephen Zaniboni for Cause 44
Mar 18, 2015: Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer 45
Jan 06, 2015: Former President of BIO Joins Trovagene's Board of Directors 46
Government and Public Interest 47
Jan 26, 2015: Trovagene's Chief Scientific Officer to Present Precision Cancer Monitoring Platform Overview at the Personalized Medicine World Conference 47
Product News 48
Apr 23, 2015: Trovagene's Urine-Based HPV Assay to Be Featured in Presentation at the 13th Annual Cervical Cancer Conference and HPV Consortium in Beijing 48
Feb 09, 2015: Clinical Results Demonstrate High Sensitivity of Trovagene's Urine-Based HPV Assay for the Detection of High Risk HPV and Pre-Cancerous Cervical Lesions 49
Jan 20, 2015: Clinical Study Results Presented at the 2015 ASCO GI Support Utility of Trovagene's Precision Cancer Monitoring Platform in Colorectal and Pancreatic Cancer Patients 50
Clinical Trials 52
Feb 09, 2015: Clinical Results Demonstrate High Sensitivity of Trovagene's Urine-Based HPV Assay for the Detection of High Risk HPV and Pre-Cancerous Cervical Lesions 52
Other Significant Developments 53
Apr 11, 2016: Trovagene Enters Into Preferred Provider Agreement with Stratose PPO Network 53
Feb 24, 2016: Trovagene Enters into Preferred Provider Agreement with Three Rivers Provider Network 54
Jan 08, 2015: Trovagene and City of Hope Collaborate To Monitor EGFR Mutational Status in Lung Cancer Patients 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables
TrovaGene, Inc., Medical Equipment, Key Facts, 2014 1
TrovaGene, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
TrovaGene, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
TrovaGene, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
TrovaGene, Inc., Deals By Market, 2010 to YTD 2016 9
TrovaGene, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 11
Trovagene Enters Into Licensing Agreement with GenSignia IP 13
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 14
TrovaGene Enters Into Licensing Agreement With Brunangelo Falini 15
TrovaGene Enters Into An Agreement With Skyline Diagnostics 16
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 17
TrovaGene Enters Into RandD Agreement With PerkinElmer Health Sciences 18
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 20
Trovagene Raises USD40.3 Million in Public Offering of Shares 21
Trovagene Completes Public Offering of Shares for USD23 Million 23
Trovagene Completes Private Placement Of Shares For US$15 Million 25
Trovagene Completes Private Placement Of Units For US$4 Million 27
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 28
TrovaGene, Inc., Key Competitors 30
TrovaGene, Inc., Key Employees 31
TrovaGene, Inc., Other Locations 32

List of Figures
TrovaGene, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
TrovaGene, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
TrovaGene, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
TrovaGene, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 7
TrovaGene, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
TrovaGene, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 9

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.